Research and development of pharmaceuticals and vaccines focusing on respiratory, immunology, oncology, HIV, and infectious diseases.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
A
The organization is among the top 5% of organizations with the most committed CSR communication, among comparable organizations.
Leading organizations
Sanofi
A
Research, development, production, and distribution of vaccines to prevent various infectious diseases.
ipbs-toulouse (cnrs-ut3)
B
Research and development in cancer, infection, and inflammation to improve therapeutics.
Chiesi SAS
B
Development and marketing of pharmaceuticals in respiratory, neonatology, transplantation, and rare diseases.
Initiatives identified among leaders
Développer des stratégies pour réduire les émissions de gaz à effet de serre
“Sanofi se fixe pour objectif de réduire ses émissi...” - Sanofilutte contre les discriminations en entreprise
“Sanofi lutte contre les discriminations en entrepr...” - SanofiOrganisation d'une table ronde institutionnelle
“Chiesi SAS organise une table ronde institutionnel...” - Chiesi SAS58% of similar organizations communicate on CSR issues
+3138 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports